September 25, 2019 / Clinical Trials

Santhera Shares Fall 2019 Community Update

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

Santhera has shared a community update on the company’s Duchenne drug development programs and their partnership with ReveraGen.

Click here to download.

Join Our Mailing List

This field is for validation purposes and should be left unchanged.
BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo